Ladenburg Thalmann Financial Services’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	324	–	–	﹤0.01%	5129
2019 Q3	$2K	Sell	324 -275	-46%	-$1.9K	﹤0.01%	5033
2019 Q2	$4K	Sell	599 -1	-0.2%	-$8	﹤0.01%	4819
2019 Q1	$6K	Buy	600 +25	+4%	+$249	﹤0.01%	4606
2018 Q4	$5K	Buy	+575	New	+$8.29K	﹤0.01%	4628
2018 Q3	–	Sell	-25	Closed	–	–	5375
2018 Q2	$0	Hold	25	–	–	﹤0.01%	5177
2018 Q1	$0	Sell	25 -267	-91%	-$4.29K	﹤0.01%	5243
2017 Q4	$12K	Buy	292 +21	+8%	+$942	﹤0.01%	4101
2017 Q3	$15K	Buy	271 +235	+653%	+$39.6K	﹤0.01%	3862
2017 Q2	$6K	Buy	+36	New	+$6.31K	﹤0.01%	4280

Other funds holding SIOX

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SIOX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Sio Gene Therapies Inc. Common Stock (SIOX) position steady in Q4 2019 at 324 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5129.

Ladenburg Thalmann Financial Services first reported a position in SIOX in Q2 2017 and has held it in 10 quarters since. The position peaked at $15K in Q3 2017. 48 funds tracked by Wall St. Rank hold SIOX as of Q4 2019.

Ladenburg Thalmann Financial Services held 324 shares of Sio Gene Therapies Inc. Common Stock worth $2K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Sio Gene Therapies Inc. Common Stock share count unchanged in Q4 2019.
Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5129 holding.
Ladenburg Thalmann Financial Services first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2017 and has held it in 10 quarters since.
Ladenburg Thalmann Financial Services's Sio Gene Therapies Inc. Common Stock position peaked at $15K in Q3 2017.
48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.